日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business

Bayer to invest more in health, nutrition sector

By ZHENG YIRAN | China Daily | Updated: 2025-04-15 00:00
Share
Share - WeChat

Acknowledging China's foreign business environment and opening-up policies for multinational corporations, German life sciences company Bayer is committed to investing in essential health and nutrition solutions in the country in order to serve a broad base of patients, consumers and growers, said its top executive.

"I sincerely appreciate the Chinese government for its recent initiatives aimed at opening up the cell and gene therapy area to foreign investment. The pilot program, introduced by the Chinese government in 2024, is a significant step forward, allowing foreign businesses to participate in the development and commercialization of these groundbreaking therapies," said Bill Anderson, CEO of Bayer.

Anderson made the remarks after he, together with around 40 other representatives of the international business community, met with China's top leadership in Beijing on March 28.

He said China has always encouraged a friendly business environment and opening-up policies for MNCs.

Whether from an innovation or market perspective, China has immeasurable potential and is one of Bayer's important global strategic pillars. The introduction of the 2025 Action Plan for Stabilizing Foreign Investment also allows the company to see more benefits. Relaxed market access, strengthened intellectual property protection, optimized business environment, facilitation of talent exchange, improved supply chain stability and deepened international cooperation will open up greater possibilities for Bayer's development in China, said the company's spokesperson earlier this year.

In 2024 alone, the company initiated several projects in China, including a new consumer health factory in Jiangsu province, with an investment of 600 million yuan ($82.4 million). Last September, it opened Bayer Co Lab in Shanghai, nurturing innovations in cell and gene therapy as well as oncology.

With chronic disease being an increasing challenge in China, Bayer is winning the market, as it has expertise in the prevention and treatment of major chronic diseases such as cardiovascular diseases, stroke and diabetes, bringing new hope for chronic disease management.

And now, with the government's favorable policies, its pace toward innovation is even faster. On Sept 7, the Ministry of Commerce, the National Health Commission, together with the National Medical Products Administration, issued a guideline on carrying out pilot projects to expand opening-up in the medical field, enabling foreign companies to be engaged in the development and application of human stem cell, gene diagnosis and treatment technologies in the pilot free trade zones in Beijing, Shanghai and Guangdong province, as well as Hainan Free Trade Port.

During the meeting in Beijing on March 28, China's top leadership noted that China has been and will remain an ideal, secure and promising destination for foreign investors, and that investing in China is investing in the future.

"The meeting with MNC CEOs signifies its determination in multilateralism and globalization, its opening gesture to the outside world as well as its highlight in cooperation and win-win development. Looking forward, the country should continue to prioritize its business environment, expand market access, enhance policy support and promote international cooperation," said Wang Peng, an associate research fellow at the Beijing Academy of Social Sciences.

In 2024, a total of 59,080 new foreign-invested enterprises were established in China, up 9.9 percent year-on-year. Over the past five years, the return rate of foreign direct investment in the country has remained at approximately 9 percent, ranking among the highest in the world.

 

Bill Anderson, CEO of Bayer

 

 

Bayer's booth at the seventh CIIE in Shanghai in November. CHINA DAILY

 

 

Today's Top News

Editor's picks

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 久久月| 色精品| 国产福利在线观看永久免费 | 日韩av免费 | 欧美精品99毛片免费高清观看 | 亚洲在线偷拍自拍 | 国产午夜精品视频免费不卡69堂 | 草草视频在线观看 | 亚洲精品一区二区三区福利 | 天天干天天在线 | 日韩成人在线视频 | 精品人妻无码一区二区三区手机板 | 奇米影视在线播放 | 国产亚洲女人久久久久久 | v视界成人影院在线视频 | 久久久久久久99精品免费观看 | 91精选视频| 日产国产精品久久久久久 | 国产成人精品免费午夜 | 欧美中文字幕一区二区 | 日韩在线不卡 | 久久96国产精品 | 成人午夜视频在线观看 | 精品欧美成人高清视频在线观看 | 亚洲精品国产精品乱码不97 | 久久99综合国产精品亚洲首页 | 亚洲亚洲人成综合网络 | 国产综合亚洲精品一区二 | 亚洲免费一区 | 天天综合久久 | 狠狠五月深爱婷婷网免费 | 人人舔人人爱 | 日韩美女一区二区三区在线观看 | 日本精品久久无码影院 | 国产精品一卡二卡三卡 | 国产精品揄拍一区二区久久 | 亚洲综合色一区二区三区另类 | 欧美福利在线 | 欧美成人18 | 日韩一区二区三区四区 | 欧美精品一二三区 |